Glaxosmithkline Share News (GSK)

Glaxo Gets Good ViiV Treatment Results, Outlines New Medicines

GSK aims to file up to 20 new drugs for approval by 2020

LONDON, Nov 3 (Reuters) - GlaxoSmithKline said on Tuesday it had the potential to file up to 20 new drugs for approval before 2020 as it seeks to revitalise a portfolio hit by falling sales of best-selling inhaled lung treatment Advair. Britain's biggest drugmaker is trying to boost low inv

PRESS: Pfizer Eyed Glaxo Bid Before Entering Allergan Talks - FT

Sunday newspaper round-up: Renminbi, GSK's pipeline, Brexit worry,

(ShareCast News) - China's currency, the renminbi, could be promoted to the International Monetary Fund's list of global reserve currencies this week, sending an estimated $1trn (£650bn) of reserves flowing into the yuan. The momentous decision would give fresh impetus to Beijing's reform efforts, t

Drugged up: GSK, Roche and Sanofi to set out their stalls

* R&D under microscope at GSK and Roche on Nov. 3 and 5 * New CEO's strategy main focus at Sanofi on Nov. 6 By Ben Hirschler LONDON, Nov 1 (Reuters) - Three of Europe's top drugmakers - GlaxoSmithKline, Roche and Sanofi - face health checks this week at high-profile presentation

Pfizer Collaborates With Glaxo On Portable Pharmaceutical Development

UPDATE 6-Pfizer said to be in talks with Allergan to forge $330 bln drugs giant

* Drug companies have held early talks, WSJ and FT say * Merger would create world's biggest healthcare group * Pfizer and Allergan decline to comment (Adds Allergan shares up in premarket trade) By Natalie Grover and Christian Plumb Oct 28 (Reuters) - Pharmaceutical gia

CORRECTED-You probably have herpes, the WHO says

(Corrects age range in third paragraph to 15-49 from 17-49) By Tom Miles GENEVA, Oct 28 (Reuters) - Two-thirds of the world's population under 50 have the highly infectious herpes virus that causes cold sores around the mouth, the World Health Organization said on Wednesday, in its fi

BROKER RATINGS SUMMARY: Credit Suisse Upgrades Diageo To Outperform

LONDON MARKET CLOSE: Oil, Gold Stocks Boost UK Shares Ahead Of Fed

London close: Stocks rally ahead of Fed's interest rate decision

(ShareCast News) - The London stock market closed higher on Wednesday before the Federal Reserve's decision on interest rates. The FTSE ended up 72.53 points to 6,437.80. The Fed releases its policy decision at 1800 GMT and is expected to keep rates at 0.25% amid low inflation and concerns about th

Don't bank on U.S. drug price rises, warns GSK boss

By Ben Hirschler LONDON, Oct 28 (Reuters) - Pharmaceutical companies cannot depend on ever increasing prices in the United States and will need to find a new balance between incentives for innovation and access to medicines, according to the chief executive of GlaxoSmithKline. High dr

UPDATE 2-GlaxoSmithKline beats forecasts as HIV drugs, flu vaccines shine

* CEO says benefits of Novartis asset swap becoming evident * Q3 core EPS 23.0 pence vs consensus 19.3p; shares up 3 pct (Adds further CEO and analyst comments) By Ben Hirschler LONDON, Oct 28 (Reuters) - GlaxoSmithKline reported better-than-expected earnings on Wednesday, hel

FTSE 100 movers: Glaxo jumps on results; Meggitt tumbles after profit warning

(ShareCast News) - London's FTSE 100 index was up 0.8% to 6,415.65 at 1400 GMT as investors awaited the Federal Reserve's policy announcement, which is due after the European close. Pharmaceuticals giant GlaxoSmithKline was the standout gainer after its third-quarter revenue and core earnings per sh

BUZZ-GSK rallies after Q3 earnings beat expectations

** GlaxoSmithKline rises to trade up 4.2 pct after Q3 earnings beat consensus ** Q3 core EPS 23p v 19.3p expected by analysts, according to Thomson Reuters data ** Top riser on FTSE 100 with pharma peers also higher ** AstraZeneca up 2 pct (RM: alasdair.pal.thomsonreuters.